China's NMPA has approved a rare-disease therapy for commercial sales to treat narcolepsy type 1 in individuals aged 16 and older. The unnamed drug previously received fast-track status in the US and orphan-drug designation in Japan and the EU, indicating international recognition for its importance.
Novo Nordisk is suing Eli Lilly, alleging "false and misleading" advertisements for its weight-loss and anti-diabetes treatments, Zepbound and Mounjaro. Novo Nordisk claims Lilly used outdated studies comparing its highest doses against lower doses of Novo Nordisk's drugs, creating a deceptive impression of superiority. Eli Lilly defends its ads, citing the Surmount-5 trial as the only direct comparison.
The US trade deficit ballooned by 42.2% in May to $77.6 billion, driven by a 3.3% rise in imports of goods like pharmaceuticals, mobile phones, and semiconductors, while exports fell 3.2%. This marks the largest monthly increase in a year, coinciding with AI spending and record petroleum imports.
Russian Prime Minister Mikhail Mishustin stated that Russia sees potential for joint development of various vessels and underwater robotic systems with Indonesia. Other areas of interest include metallurgy, pharmaceuticals, medical equipment, and digital technologies.
South Korea's pharmaceutical exports exceeded $10 billion in 2025, a 12.4% increase from the previous year. Production also hit a record high of 33.8 trillion won, driven by biopharmaceuticals and contract manufacturing capabilities.
Alibaba Group will pay $600 million to resolve a US Department of Justice investigation into allegations its platforms facilitated the sale of thousands of illegal pharmaceuticals and controlled substances into the US. The settlement involves non-prosecution agreements with Alibaba and AUS Merchant Services.
The US has launched a Section 301 investigation into Germany concerning alleged underpayment for innovative pharmaceuticals, potentially impacting US commerce. Germany's proposed healthcare reforms and fast-tracking of legislation to reduce drug spending are key concerns.
Breckenridge Pharmaceuticals thu hồi gần 370.000 lọ thuốc Duloxetine do tạp chất N-nitroso-duloxetine có thể gây ung thư. FDA xếp loại thu hồi là Nhóm II, ảnh hưởng tạm thời hoặc có thể khắc phục về y tế.
Taiwanese entrepreneur Lai Caida shared his entrepreneurial journey at the 18th Straits Forum in Xiamen, aiming to become the "SpaceX of the pharmaceutical industry" with his AI-powered drug delivery platform, Jitaikeji. The company, which started in Hangzhou, has now listed in Hong Kong and Lai invited other Taiwanese youth to pursue opportunities in mainland China.
Trade turnover between Russia and Uzbekistan surged by nearly 30% in the first quarter of this year, following a 12% increase last year to $11.5 billion. Joint projects span industry, energy, transport, and agriculture.
India and Venezuela are expanding cooperation, especially in energy, with Venezuela becoming India's third-largest crude oil supplier. Discussions aim for a structured energy partnership, covering upstream and downstream sectors, leveraging Venezuela's vast oil reserves and India's growing demand.
Russia's Economic Development Minister Maxim Reshetnikov stated readiness to enhance agricultural cooperation with Brazil, focusing on increased imports of coffee, fruits, and meat, and collaboration in plant breeding and education. Russia also seeks dialogue on drug registration with Brazil's health agency.
Indian companies are set to invest over $20.5 billion dollars in the United States in various sectors including technology, manufacturing, and pharmaceuticals. "Twelve Indian firms alone announced 1.1 billion dollars in new investments today and these partnerships are creating American jobs and strengthening supply chains," US ambassador to India Sergio Gor said.
The FDA approved the first gene therapy to restore hearing for people born deaf, developed by Regeneron Pharmaceuticals. The treatment targets a rare genetic defect affecting about 50 U.S. children annually, caused by a defective OTOF gene. In clinical trials, 80% of patients achieved significant hearing restoration and 42% gained normal hearing, with effects lasting at least two years.
Servier a mené «avec succès» son offre publique d’achat visant la totalité des actions de l’entreprise biopharmaceutique américaine Day One Biopharmaceuticals.
